At the news
? BEARISHIMPACT 7/10 CLUSTER filed Apr 5, 2026 at 20:00 ET
Travere Therapeutics insiders executed a significant cluster of open-market sales totaling $2.1 million over seven days, led by the General Counsel selling over $1.75 million of shares. The CFO and CMO also sold smaller amounts, while non-cash transactions (grants, exercises) were routine. This wave of selling by multiple executives signals potential lack of confidence ahead of key catalysts.
- General Counsel Elizabeth Reed sold 42,726 shares for $1.76 million in open-market transactions on April 14–15, 2026.
- CFO Christopher Cline and CMO Jula Inrig each sold approximately $45,000–$47,000 in stock, contributing to a total of $2.1 million in insider sales over 7 days.
- Non-cash transactions included stock grants and option exercises totaling $190,800, which are standard and not economically significant.
- Total open-market sales represent ~0.05% of the $3.9B market cap, but concentration among C-suite executives amplifies the signal.
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access